Optimizing the Differentiation of Cardiomyocytes from Human Induced Pluripotent-Derived Stem Cells
- 31 July 2021
- book chapter
- Published by Springer Nature
- Vol. 2319, 51-60
Abstract
Cardiovascular disease is a worldwide health issue that affects millions of lives every year, and thus, researchers are in need of high-throughput model systems with which to investigate mechanisms of disease and to develop and test potential therapies. The use of human-derived induced pluripotent stem cells (iPSCs) differentiated into cardiomyocytes aims to address this need. While cardiac differentiation protocols have been established previously in iPSCs, optimization of cardiac differentiation remains crucial to obtaining high quality cardiomyocytes for future experimental analyses. Important factors to consider include cell density and rate of proliferation, temporal regulation of media changes throughout the differentiation process, and the concentration of the chemicals utilized. In this chapter, we present a detailed protocol to outline the process of differentiating cardiomyocytes from human iPSCs via modulation of Wnt signaling, characterization of cardiomyocytes by immunofluorescence, as well as guidelines for troubleshooting and optimizing these techniques.Keywords
This publication has 26 references indexed in Scilit:
- Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditionsCell Research, 2013
- Generation of human induced pluripotent stem cells from urine samplesNature Protocols, 2012
- Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signalingProceedings of the National Academy of Sciences, 2012
- Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated CardiomyopathyScience Translational Medicine, 2012
- Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell cultureDisease Models & Mechanisms, 2012
- Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndromeNature, 2011
- Reprogramming of Human Peripheral Blood Cells to Induced Pluripotent Stem CellsCell Stem Cell, 2010
- Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndromeNature, 2010
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006